Equities analysts expect athenahealth, Inc. (NASDAQ:ATHN) to report $0.63 earnings per share (EPS) for the current fiscal quarter, Zacks reports. Twenty analysts have provided estimates for athenahealth’s earnings. The highest EPS estimate is $0.77 and the lowest is $0.56. athenahealth reported earnings per share of $0.62 during the same quarter last year, which indicates a positive year-over-year growth rate of 1.6%. The business is scheduled to report its next quarterly earnings report on Thursday, February 1st.
According to Zacks, analysts expect that athenahealth will report full-year earnings of $2.01 per share for the current financial year, with EPS estimates ranging from $1.82 to $2.15. For the next fiscal year, analysts forecast that the business will report earnings of $2.80 per share, with EPS estimates ranging from $2.22 to $3.46. Zacks’ EPS calculations are a mean average based on a survey of research analysts that cover athenahealth.
athenahealth (NASDAQ:ATHN) last issued its earnings results on Thursday, October 19th. The health services provider reported $0.56 EPS for the quarter, topping analysts’ consensus estimates of $0.50 by $0.06. The company had revenue of $304.60 million for the quarter, compared to analysts’ expectations of $310.52 million. athenahealth had a net margin of 2.65% and a return on equity of 6.78%. The firm’s revenue was up 10.1% compared to the same quarter last year. During the same quarter last year, the company earned $0.60 EPS.
A number of research firms have issued reports on ATHN. TheStreet upgraded shares of athenahealth from a “c” rating to a “b-” rating in a research report on Thursday, July 20th. Evercore ISI restated an “outperform” rating and issued a $163.00 price objective (up previously from $155.00) on shares of athenahealth in a research report on Saturday, July 22nd. Wells Fargo & Company restated an “outperform” rating and issued a $190.00 price objective (up previously from $130.00) on shares of athenahealth in a research report on Saturday, July 22nd. UBS AG restated a “positive” rating and issued a $175.00 price objective (up previously from $157.00) on shares of athenahealth in a research report on Monday, July 24th. Finally, First Analysis cut shares of athenahealth from an “equal weight” rating to an “underweight” rating and boosted their price objective for the company from $99.00 to $125.00 in a research report on Monday, July 24th. Two investment analysts have rated the stock with a sell rating, fourteen have issued a hold rating and eleven have issued a buy rating to the company. athenahealth has an average rating of “Hold” and a consensus target price of $143.22.
In related news, CEO Jonathan Bush sold 4,000 shares of the business’s stock in a transaction dated Friday, September 1st. The shares were sold at an average price of $139.77, for a total transaction of $559,080.00. Following the sale, the chief executive officer now owns 319,807 shares of the company’s stock, valued at $44,699,424.39. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Daniel P. Haley sold 1,583 shares of the business’s stock in a transaction dated Monday, October 2nd. The stock was sold at an average price of $124.56, for a total transaction of $197,178.48. Following the sale, the insider now directly owns 13,408 shares in the company, valued at approximately $1,670,100.48. The disclosure for this sale can be found here. Insiders have sold 12,783 shares of company stock worth $1,680,236 in the last three months. 3.20% of the stock is currently owned by insiders.
A number of institutional investors have recently modified their holdings of the business. FMR LLC raised its holdings in athenahealth by 0.8% in the second quarter. FMR LLC now owns 5,975,119 shares of the health services provider’s stock worth $839,803,000 after buying an additional 47,341 shares during the last quarter. Janus Henderson Group PLC purchased a new position in athenahealth in the second quarter worth about $713,856,000. Vanguard Group Inc. raised its holdings in athenahealth by 1.8% in the second quarter. Vanguard Group Inc. now owns 3,100,643 shares of the health services provider’s stock worth $435,795,000 after buying an additional 53,361 shares during the last quarter. Capital Research Global Investors raised its holdings in athenahealth by 15.5% in the second quarter. Capital Research Global Investors now owns 2,041,714 shares of the health services provider’s stock worth $286,963,000 after buying an additional 273,660 shares during the last quarter. Finally, BlackRock Inc. raised its holdings in athenahealth by 2.0% in the second quarter. BlackRock Inc. now owns 1,631,993 shares of the health services provider’s stock worth $229,377,000 after buying an additional 32,146 shares during the last quarter.
COPYRIGHT VIOLATION WARNING: “Zacks: Brokerages Anticipate athenahealth, Inc. (ATHN) Will Announce Earnings of $0.63 Per Share” was posted by The Ledger Gazette and is owned by of The Ledger Gazette. If you are viewing this report on another site, it was illegally copied and republished in violation of United States and international copyright & trademark legislation. The correct version of this report can be read at https://ledgergazette.com/2017/11/18/zacks-brokerages-anticipate-athenahealth-inc-athn-will-announce-earnings-of-0-63-per-share.html.
Shares of athenahealth (ATHN) traded down $3.91 during trading hours on Monday, reaching $124.36. 339,148 shares of the company were exchanged, compared to its average volume of 762,557. The stock has a market cap of $5,035.02, a PE ratio of 106.63, a PEG ratio of 5.06 and a beta of 1.57. athenahealth has a one year low of $90.11 and a one year high of $158.66. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.67 and a current ratio of 1.67.
athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with MarketBeat.com's FREE daily email newsletter.